-
1
-
-
34548429308
-
Levamisole: an analytical profile
-
A.M. Valentino and K. Fuentecilla. Levamisole: an analytical profile. Microgram J. 3: 134-137 (2005).
-
(2005)
Microgram J
, vol.3
, pp. 134-137
-
-
Valentino, A.M.1
Fuentecilla, K.2
-
2
-
-
34548405908
-
Unusual adulterants in cocaine seizure on Italian clandestine market
-
N. Fucci. Unusual adulterants in cocaine seizure on Italian clandestine market. Forensic Sci. Int. 172(2-3): e1 (2007).
-
(2007)
Forensic Sci. Int.
, vol.172
, Issue.2-3
-
-
Fucci, N.1
-
4
-
-
60849110287
-
Agranulocytosis after consumption of cocaine adulterated with levamisole
-
N.Y. Zhu, D.F. Legatt, and A.R. Turner. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann. Intern. Med. 150: 287-289 (2009).
-
(2009)
Ann. Intern. Med.
, vol.150
, pp. 287-289
-
-
Zhu, N.Y.1
Legatt, D.F.2
Turner, A.R.3
-
5
-
-
71049137773
-
Levamisole tinted cocaine causing severe neutropenia in Alberta and British Columbia
-
L. Knowles, J.A. Buxton, N. Skuridina, I. Achebe, D. Legatt, S. Fan, N. Yan Zhu, and J. Talbot. Levamisole tinted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct. J. 6: 30 (2009).
-
(2009)
Harm Reduct. J.
, vol.6
, pp. 30
-
-
Knowles, L.1
Buxton, J.A.2
Skuridina, N.3
Achebe, I.4
Legatt, D.5
Fan, S.6
Yan Zhu, N.7
Talbot, J.8
-
6
-
-
72649097525
-
Agranulocytosis associated with cocaine use-four states, March 2008-November 2009
-
Centers for Disease Control and Prevention (CDC)
-
Centers for Disease Control and Prevention (CDC). Agranulocytosis associated with cocaine use-four states, March 2008-November 2009. Morb. Mortal.Wkly. Rep. 58: 1381-1385 (2009).
-
(2009)
Morb. Mortal. Wkly. Rep.
, vol.58
, pp. 1381-1385
-
-
-
7
-
-
77949385200
-
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine
-
D.R. Czuchlewsk, M. Brackney, C. Ewers, J. Manna, M.H. Fekrazad, A. Martinez, K.B. Nolte, B. Hjelle, I. Rabinowitz, B.R. Curtis, J.G. Mc-Farland, J. Baumbach, and K. Foucar. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am. J. Clin. Pathol. 133: 466-472 (2010).
-
(2010)
Am. J. Clin. Pathol.
, vol.133
, pp. 466-472
-
-
Czuchlewsk, D.R.1
Brackney, M.2
Ewers, C.3
Manna, J.4
Fekrazad, M.H.5
Martinez, A.6
Nolte, K.B.7
Hjelle, B.8
Rabinowitz, I.9
Curtis, B.R.10
Mc-Farland, J.G.11
Baumbach, J.12
Foucar, K.13
-
8
-
-
77955919530
-
Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J
-
J.M.Waller, J.D. Feramisco, L. Alberta-Wszolek, T.H. McCalmont, and L.P. Fox. Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J. Am. Acad. Dermatol. 63(3): 530-535 (2010).
-
(2010)
Am. Acad. Dermatol.
, vol.63
, Issue.3
, pp. 530-535
-
-
Waller, J.M.1
Feramisco, J.D.2
Alberta-Wszolek, L.3
McCalmont, T.H.4
Fox, L.P.5
-
9
-
-
77953395872
-
Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole
-
M. Bradford, B. Rosenberg, J. Moreno, and G. Dumyati. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann. Intern. Med. 152: 758-759 (2010).
-
(2010)
Ann. Intern. Med.
, vol.152
, pp. 758-759
-
-
Bradford, M.1
Rosenberg, B.2
Moreno, J.3
Dumyati, G.4
-
10
-
-
74549117199
-
The possible role of levamisole in illicit cocaine preparations
-
L.P Raymond and D.S. Isenschmid. The possible role of levamisole in illicit cocaine preparations. J. Anal. Toxicol. 33(9): 620-622 (2009).
-
(2009)
J. Anal. Toxicol.
, vol.33
, Issue.9
, pp. 620-622
-
-
Raymond, L.P.1
Isenschmid, D.S.2
-
11
-
-
0037663202
-
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
-
B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75: 3019-3030 (2003).
-
(2003)
Anal. Chem.
, vol.75
, pp. 3019-3030
-
-
Matuszewski, B.K.1
Constanzer, M.L.2
Chavez-Eng, C.M.3
-
12
-
-
0022620425
-
Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine
-
E. Kouassi, G. Caille, L. Lery, L. Lariviere, and M. Vezina. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm. Drug Dispos. 7: 71-89 (1986).
-
(1986)
Biopharm. Drug Dispos.
, vol.7
, pp. 71-89
-
-
Kouassi, E.1
Caille, G.2
Lery, L.3
Lariviere, L.4
Vezina, M.5
-
13
-
-
0031935625
-
Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer
-
J.M. Reid, J.S. Kovach, M.J. O'Connell, P.G. Bagniewski, and C.G. Moertel. Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer. Cancer Chemother. Pharmacol. 41: 477-484 (1998).
-
(1998)
Cancer Chemother. Pharmacol.
, vol.41
, pp. 477-484
-
-
Reid, J.M.1
Kovach, J.S.2
O'Connell, M.J.3
Bagniewski, P.G.4
Moertel, C.G.5
-
15
-
-
0018764555
-
Granulocytotoxic autoantibodies in HLAB27 neutropenic patients
-
S.I. Drew and B.M. Carter. Granulocytotoxic autoantibodies in HLAB27 neutropenic patients. Transplantation 27: 436-437 (1979).
-
(1979)
Transplantation
, vol.27
, pp. 436-437
-
-
Drew, S.I.1
Carter, B.M.2
|